{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:22:01Z","timestamp":1788110521330,"version":"build-2803163510"},"reference-count":86,"publisher":"EDITORA SCIENTIFIC","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz. J. Psychiatry"],"DOI":"10.1590\/1516-4446-2018-0177","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T14:23:37Z","timestamp":1551536617000},"page":"324-335","source":"Crossref","is-referenced-by-count":35,"title":["Brazilian guidelines for the management of psychomotor agitation. Part 2. Pharmacological approach"],"prefix":"10.47626","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5201-8515","authenticated-orcid":false,"given":"Leonardo","family":"Balda\u00e7ara","sequence":"first","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Universidade Federal do Tocantins (UFT), Brazil; Secretaria de Estado de Sa\u00fade do Tocantins, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre P.","family":"Diaz","sequence":"additional","affiliation":[{"name":"Universidade do Sul de Santa Catarina (UNISUL), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f4nica","family":"Leite","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Secretaria de Estado de Sa\u00fade do Tocantins, Brazil; Secretaria de Sa\u00fade do Munic\u00edpio de Palmas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas A.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Universidade Salvador (UNIFACS), Brazil; Escola Bahiana de Medicina e Sa\u00fade P\u00fablica (EBMSP), Brazil; Faculdade de Tecnologia e Ci\u00eancias (FTC), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto M.","family":"dos Santos","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Universidade Federal da Para\u00edba (UFPB), Brazil; Pronto Atendimento em Sa\u00fade Mental, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente de P.","family":"Gomes J\u00fanior","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Associa\u00e7\u00e3o Psiqui\u00e1trica do Piau\u00ed (APPI), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie L.B.","family":"Calfat","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Faculdade de Medicina da Santa Casa de S\u00e3o Paulo (FCMSCSP), Brazil; Centro de Aten\u00e7\u00e3o Integrada \u00e0 Sa\u00fade Mental, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via","family":"Ismael","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Faculdade de Medicina do ABC, Brazil; Coordenadoria de Sa\u00fade Mental, Brazil; Universidade de S\u00e3o Caetano do Sul, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia A.M.","family":"P\u00e9rico","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Faculdade de Medicina do ABC, Brazil; Coordenadoria de Sa\u00fade Mental, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deisy M.","family":"Porto","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Instituto de Psiquiatria de Santa Catarina, Brazil; Coordena\u00e7\u00e3o Estadual de Sa\u00fade Mental, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.K.","family":"Zacharias","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Secretaria de Estado da Sa\u00fade de S\u00e3o Paulo, Brazil; Secretaria de Sa\u00fade do Munic\u00edpio de Sorocaba, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quirino","family":"Cordeiro","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Faculdade de Medicina da Santa Casa de S\u00e3o Paulo (FCMSCSP), Brazil; Coordena\u00e7\u00e3o-Geral de Sa\u00fade Mental, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3423-7076","authenticated-orcid":false,"given":"Ant\u00f4nio Geraldo","family":"da Silva","sequence":"additional","affiliation":[{"name":"Asociaci\u00f3n Psiqui\u00e1trica de Am\u00e9rica Latina (APAL), Brazil; ABP, Brazil; Universidade do Porto\/Conselho Federal de Medicina (CFM), Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng C.","family":"Tung","sequence":"additional","affiliation":[{"name":"Associa\u00e7\u00e3o Brasileira de Psiquiatria, Brazil; Universidade de S\u00e3o Paulo (USP), Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27448","published-online":{"date-parts":[[2019,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","article-title":"The psychopharmacology of agitation: Consensus Statement of the American Association for Emergency Psychiatry Project Beta Psychopharmacology Workgroup","volume":"13","author":"Wilson MP","year":"2012","journal-title":"West J Emerg Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S1516-44462011000100008","article-title":"Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone","volume":"33","author":"Balda\u00e7ara L","year":"2011","journal-title":"Rev Bras Psiquiatr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1192\/bjp.180.6.485","article-title":"Rapid tranquillisation: time for a reappraisal of options for parenteral therapy","volume":"180","author":"McAllister-Williams RH","year":"2002","journal-title":"Br J Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/15622975.2015.1132007","article-title":"Assessment and management of agitation in psychiatry: Expert consensus","volume":"17","author":"Garriga M","year":"2016","journal-title":"World J Biol Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clinthera.2010.03.006","article-title":"Systematic reviews of assessment measures and pharmacologic treatments for agitation","volume":"32","author":"Zeller SL","year":"2010","journal-title":"Clin Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1590\/S1516-44462010000600006","article-title":"Manejo de paciente agitado ou agressivo","volume":"32","author":"Mantovani C","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5811\/westjem.2011.9.6864","article-title":"Verbal De-escalation of the Agitated Patient: Consensus Statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup","volume":"13","author":"Richmond JS","year":"2012","journal-title":"West J Emerg Med"},{"key":"ref8","series-title":"Braz J Psychiatry","volume-title":"Brazilian guidelines for the management of psychomotor agitation. Part 1. Non-pharmacological approach","author":"Balda\u00e7ara L","year":"2018"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1017\/S1092852914000054","article-title":"The psychopharmacology of violence: making sensible decisions","volume":"19","author":"Citrome L","year":"2014","journal-title":"CNS Spectr"},{"key":"ref10","series-title":"Oxford Centre for Evidence-based Medicine \u2013 Levels of Evidence (March 2009)","year":"2009"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/B:PSAQ.0000031791.53142.85","article-title":"New treatments for agitation","volume":"75","author":"Citrome L","year":"2004","journal-title":"Psychiatr Q"},{"key":"ref12","first-page":"46","article-title":"Clinical challenges in the pharmacologic management of agitation","volume":"17","author":"Ng AT","year":"2010","journal-title":"Prim Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0b13e318033bd5e","article-title":"Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole","volume":"27","author":"Zimbroff DL","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"ref14","series-title":"Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications","author":"Stahl S","year":"2008"},{"key":"ref15","first-page":"CD007445","article-title":"Chlorpromazine for psychosis induced aggression or agitation","author":"Ahmed U","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/hup.2376","article-title":"A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia","volume":"29","author":"Suzuki H","year":"2014","journal-title":"Hum Psychopharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study","volume":"56","author":"Isbister GK","year":"2010","journal-title":"Ann Emerg Med"},{"key":"ref18","series-title":"Phenothiazine [Internet]","year":"2018"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0033-3182(73)71377-3","article-title":"Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine","volume":"14","author":"Man PL","year":"1973","journal-title":"Psychosomatics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/JCP.0000000000000050","article-title":"Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine","volume":"34","author":"Walther S","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajem.2004.02.021","article-title":"Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia","volume":"22","author":"Kinon BJ","year":"2004","journal-title":"Am J Emerg Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000120","article-title":"A double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior","volume":"34","author":"Chan HY","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.pra.0000271658.86845.81","article-title":"Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations","volume":"13","author":"Daniel DG","year":"2007","journal-title":"J Psychiatr Pract"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/ajp.156.1.142","article-title":"Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior","volume":"156","author":"Dorevitch A","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/YIC.0b013e32834fc431","article-title":"Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia","volume":"27","author":"Fang M","year":"2012","journal-title":"Int Clin Psychopharmacol"},{"key":"ref26","first-page":"CD003079","article-title":"Benzodiazepines for psychosis-induced aggression or agitation","volume":"9","author":"Gillies D","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref27","first-page":"CD005146","article-title":"Haloperidol plus promethazine for psychosis-induced aggression","volume":"11","author":"Huf G","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bmj.39339.448819.AE","article-title":"Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine","volume":"335","author":"Huf G","year":"2007","journal-title":"BMJ"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000315437","article-title":"Comparison of risperidone orodispersible tablet and intramuscular haloperidol in the treatment of acute psychotic agitation: a randomized open, prospective study","volume":"62","author":"Lim HK","year":"2010","journal-title":"Neuropsychobiology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/JCP.0b013e318253a2fe","article-title":"A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation","volume":"32","author":"MacDonald K","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.genhosppsych.2010.04.005","article-title":"A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients","volume":"32","author":"MacDonald K","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0033-3182(73)71377-3","article-title":"Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine","volume":"14","author":"Man PL","year":"1973","journal-title":"Psychosomatics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1553-2712.2004.tb00738.x","article-title":"A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients","volume":"11","author":"Nobay F","year":"2004","journal-title":"Acad Emerg Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.genhosppsych.2004.11.004","article-title":"Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study","volume":"27","author":"Preval H","year":"2005","journal-title":"Gen Hosp Psychiatry"},{"key":"ref35","first-page":"298","article-title":"Droperidol vs. haloperidol in the initial management of acutely agitated patients","volume":"45","author":"Resnick M","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v68n0115","article-title":"Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Tran-Johnson TK","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.158.7.1149","article-title":"Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia","volume":"158","author":"Wright P","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/JCP.0b013e3182839612","article-title":"Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia","volume":"33","author":"Zhang H","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YIC.0000000000000064","article-title":"Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial","volume":"30","author":"Asadollahi S","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.59.5.441","article-title":"A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia","volume":"59","author":"Breier A","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","article-title":"Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine","volume":"185","author":"Alexander J","year":"2004","journal-title":"Br J Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/JCP.0b013e3182900fd6","article-title":"Are low doses of antipsychotics effective in the management of psychomotor agitation? A randomized, rated-blind trial of 4 intramuscular interventions","volume":"33","author":"Mantovani C","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/bmj.39341.608519.BE","article-title":"Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine","volume":"335","author":"Raveendran NS","year":"2007","journal-title":"BMJ"},{"key":"ref44","series-title":"BMJ","first-page":"708","volume-title":"Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine","volume":"327","year":"2003"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/j.1875-9114.1998.tb03827.x","article-title":"A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation","volume":"18","author":"Bieniek SA","year":"1998","journal-title":"Pharmacotherapy"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4088\/JCP.v62n0303","article-title":"Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation","volume":"62","author":"Currier GW","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4088\/JCP.v65n0315","article-title":"Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam","volume":"65","author":"Currier GW","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","author":"Chan EW","year":"2013","journal-title":"Ann Emerg Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1197\/j.aem.2005.07.017","article-title":"Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam","volume":"12","author":"Martel M","year":"2005","journal-title":"Acad Emerg Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott JC","year":"2006","journal-title":"Ann Emerg Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","article-title":"Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol","volume":"16","author":"Richards JR","year":"1998","journal-title":"J Emerg Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-4679(96)00259-4","article-title":"The efficacy of intravenous droperidol in the prehospital setting","volume":"15","author":"Rosen CL","year":"1997","journal-title":"J Emerg Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical Trial","volume":"69","author":"Taylor DM","year":"2017","journal-title":"Ann Emerg Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/add.13780","article-title":"Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial","volume":"112","author":"Yap CYL","year":"2017","journal-title":"Addiction"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4088\/JCP.10m06011yel","article-title":"Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial","volume":"72","author":"Allen MH","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-5618.2011.00975.x","article-title":"Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine","volume":"14","author":"Kwentus J","year":"2012","journal-title":"Bipolar Disord"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-006-0541-x","article-title":"Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol","volume":"188","author":"Andrezina R","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/phar.1260","article-title":"Intramuscular aripiprazole in the acute management of psychomotor agitation","volume":"33","author":"De Filippis S","year":"2013","journal-title":"Pharmacotherapy"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00131746-200603000-00005","article-title":"Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Veser FH","year":"2006","journal-title":"J Psychiatr Pract"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2008.03.016","article-title":"Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders","volume":"102","author":"Agid O","year":"2008","journal-title":"Schizophr Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jemermed.2012.01.028","article-title":"Are oral medications effective in the management of acute agitation?","volume":"43","author":"Gault TI","year":"2012","journal-title":"J Emerg Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/JCP.0b013e3181db8715","article-title":"Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in Taiwan","volume":"30","author":"Hsu WY","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.genhosppsych.2008.03.004","article-title":"Olanzapine orally disintegrating tablet vs. risperidone oral solution in the treatment of acutely agitated psychotic patients","volume":"30","author":"Hatta K","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2006-950498","article-title":"Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets","volume":"39","author":"Normann C","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.jcp.0000085406.08426.a8","article-title":"Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation","volume":"23","author":"Baker RW","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"ref66","first-page":"151","article-title":"[Effectiveness results of olanzapine in acute psychotic patients with agitation in the emergency room setting: results from NATURA study]","volume":"36","author":"Escobar R","year":"2008","journal-title":"Actas Esp Psiquiatr"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-244X-13-20","article-title":"A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation","volume":"13","author":"Katagiri H","year":"2013","journal-title":"BMC Psychiatry"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15622970802688051","article-title":"Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation","volume":"10","author":"Castle DJ","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eurpsy.2010.04.005","article-title":"A prospective, observational study of the safety and effectiveness of intramuscular psychotropic treatment in acutely agitated patients with schizophrenia and bipolar mania","volume":"27","author":"Perrin E","year":"2012","journal-title":"Eur Psychiatry"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.v62n0104","article-title":"Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients","volume":"62","author":"Lesem MD","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s002130000658","article-title":"Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial","volume":"155","author":"Daniel DG","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/acps.12262","article-title":"A single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitation","volume":"130","author":"Pratts M","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"ref73","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin CE 3rd","year":"2013","journal-title":"Ochsner J"},{"issue":"Suppl 4","key":"ref74","first-page":"S114","article-title":"A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms","volume":"38","author":"Chouinard G","year":"1993","journal-title":"Can J Psychiatry"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0269881110376685","article-title":"Effects on prolongation of Bazett\u2019s corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis","volume":"25","author":"Chung AK","year":"2011","journal-title":"J Psychopharmacol"},{"key":"ref76","first-page":"9406813","article-title":"Two sudden and unexpected deaths of patients with schizophrenia associated with intramuscular injections of antipsychotics and practice guidelines to limit the use of high doses of intramuscular antipsychotics","volume":"2016","author":"Wahidi N","year":"2016","journal-title":"Case Rep Psychiatry"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0269881116684337","article-title":"Psychotropic drugs and ventricular repolarisation: the effects on QT interval, T-peak to T-end interval and QT dispersion","volume":"31","author":"Acciavatti T","year":"2017","journal-title":"J Psychopharmacol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.annemergmed.2014.12.005","article-title":"Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram","volume":"66","author":"Berling I","year":"2015","journal-title":"Ann Emerg Med"},{"key":"ref79","first-page":"541","article-title":"[Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol]","volume":"40","author":"Guy JM","year":"1991","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/ALN.0b013e31817fd8c8","article-title":"Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study","volume":"109","author":"Charbit B","year":"2008","journal-title":"Anesthesiology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11096-017-0446-2","article-title":"Development of a risk score for QTc-prolongation: the RISQ-PATH study","volume":"39","author":"Vandael E","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00134-013-3138-y","article-title":"Nonsustained ventricular tachycardia in a patient with acquired long QT syndrome after levomepromazine injection","volume":"40","author":"Pressler J","year":"2014","journal-title":"Intensive Care Med"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s40263-014-0196-9","article-title":"QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review","volume":"28","author":"Hasnain M","year":"2014","journal-title":"CNS Drugs"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1192\/bjp.bp.110.081513","article-title":"Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine","volume":"198","author":"Lesem MD","year":"2011","journal-title":"Br J Psychiatry"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.2010.10040569","article-title":"Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"168","author":"Allen MH","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"ref86","first-page":"5","article-title":"The expert consensus guideline series. Treatment of behavioral emergencies 2005","volume":"11","author":"Allen MH","year":"2005","journal-title":"J Psychiatr Pract"}],"container-title":["Brazilian Journal of Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rbp\/v41n4\/1516-4446-rbp-1516444620180177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:54:19Z","timestamp":1694649259000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1516-44462019000400324&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":86,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["S1516-44462019000400324"],"URL":"https:\/\/doi.org\/10.1590\/1516-4446-2018-0177","relation":{},"ISSN":["1809-452X","1516-4446"],"issn-type":[{"value":"1809-452X","type":"electronic"},{"value":"1516-4446","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}